These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 564138)

  • 1. Inherited combined deficiency of factor V and factor VIII: report of a case with normal factor VIII antigen and ristocetin-induced platelet aggregation.
    Cimo PL; Moake JL; Gonzalez MF; Natelson EA; Fox KR
    Am J Hematol; 1977; 2(4):385-91. PubMed ID: 564138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined factor V/VIII deficiency: a case report including levels of factor V and factor VIII coagulant and antigen as well as protein C inhibitor.
    Brown JM; Selik NR; Voelpel MJ; Mammen EF
    Am J Hematol; 1985 Dec; 20(4):401-7. PubMed ID: 3934961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.
    Stableforth P; Tamagnini GL; Dormandy KM
    Br J Haematol; 1976 Aug; 33(4):565-73. PubMed ID: 1087568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
    Barbui T; Battista R; Dini E
    Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined factor V and factor VIII deficiency among non-Ashkenazi Jews.
    Seligsohn U; Zivelin A; Zwang E
    N Engl J Med; 1982 Nov; 307(19):1191-5. PubMed ID: 6811896
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined deficiency of factor V and factor VIII. A report of another case.
    Girolami A; Violante N; Cella G; Patrassi G
    Blut; 1976 Jun; 32(6):415-22. PubMed ID: 1276481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined factor V-VIII deficiency: a case report with studies of factor V and VIII activation by thrombin.
    Hultin MB; Eyster ME
    Blood; 1981 Nov; 58(5):983-5. PubMed ID: 6794678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined congenital deficiency of factor V and factor VIII. Report of a further case with some considerations on the hetereditary transmission of this disorder.
    Girolami A; Gastaldi G; Patrassi G; Galletti A
    Acta Haematol; 1976; 55(4):234-43. PubMed ID: 816163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in combined factor V and factor VIII deficiency.
    Giddings JC; Seligsohn U; Bloom AL
    Br J Haematol; 1977 Oct; 37(2):257-64. PubMed ID: 603759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of factor VIII-related antigen using commercial antisera.
    Chediak J; Maxey B; Telfer M
    Am J Clin Pathol; 1977 May; 67(5):462-9. PubMed ID: 404869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.